Sordarins: A new class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeasts

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 9, 1998, Pages 2274-2278

  Domínguez, Juan Manuel ^a   Kelly, Valerie A ^b   Kinsman, Oonagh S ^b   Marriott, Michael S ^b   Gómez De Las Heras, Federico ^a   Martín, J Julio ^a  

^a GLAXOSMITHKLINE   (Spain)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANISOMYCIN; ANTIFUNGAL AGENT; CYCLOHEXIMIDE; ELONGATION FACTOR; EMETINE; FUSIDIC ACID; GR 135402; HOMOHARRINGTONINE; HYGROMYCIN; PAROMOMYCIN; PUROMYCIN; SORDARIN; UNCLASSIFIED DRUG; VERRUCARIN A;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDIASIS; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG SCREENING; DRUG TARGETING; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 0039058563     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.9.2274     Document Type: Article

References (24)

1. Belfield, G. P., and M. F. Tuite. 1993. Translation elongation factor 3: a fungus-specific translation factor? Mol. Microbiol. 9:411-418.
2. Carrasco, L., C. Fernandez-Puentes, and D. Vazquez. 1976. Antibiotics and compounds affecting translation by eukaryotic ribosomes. Specific enhancement of aminoacyl-tRNA binding by methylxanthines. Mol. Cell. Biochem. 10:97-122.
3. Clark, A. M. 1992. The need for new antifungal drugs, p. 1-19. In P. B. Fernandes (ed.), New approaches for antifungal drugs. Birkhäuser, Boston, Mass.
4. Coleclough, C., L. Kuhn, and I. Lefkovits. 1990. Regulation of mRNA abundance in activated T lymphocytes: identification of mRNA species affected by the inhibition of protein synthesis. Proc. Natl. Acad. Sci. USA 87: 1753-1757.
5. Colthurst, D. R., P. Chalk, M. Hayes, and M. F. Tuite. 1991. Efficient translation of synthetic and natural mRNAs in an mRNA-dependent cell-free system from the dimorphic fungus Candida albicans. J. Gen. Microbiol. 137:851-857.
6. Dittman, W. A., T. Kumada, and P. W. Majerus. 1989. Transcription of thrombomodulin mRNA in mouse hemangioma cells is increased by cycloheximide and thrombin. Proc. Natl. Acad. Sci. USA 86:7179-7182.
7. Domínguez, J. M., and J. J. Martin. 1998. Identification of elongation factor 2 as the essential protein targeted by sordarins in Candida albicans. Antimicrob. Agents Chemother. 42:2279-2283.
8. Gooday, G. W. 1995. The potential of novel antifungal drugs for the treatment of disease in the immunocompromised host. Exp. Opin. Invest. Drugs 4:679-691.
9. Hall, C. C., A. B. Bertasso, J. D. Watkins, and N. H. Georgopapadakou. 1992. Screening assays for protein synthesis inhibitors. J. Antibiot. 45:1697-1699.
10. Hauser, D., and H. P. Sigg. 1971. Isolierung und Abbau von Sordarin. Helv. Chim. Acta 54:1178-1190.
11. Herruer, M. H., W. H. Mager, H. A. Raue, P. Vreken, E. Wilms, and R. J. Planta. 1988. Mild temperature shock affects transcription of yeast ribosomal protein genes as well as the stability of their mRNAs. Nucleic Acids Res. 16: 7917-7929.
12. Kambampati, R., and K. Chakraburtty. 1997. Functional subdomains of yeast elongation factor 3. Localization of ribosome binding domain. J. Biol. Chem. 272:6377-6381.
13. Kinsman, O. S., P. A. Chalk, H. C. Jackson, R. F. Middleton, A. Shuttleworth, B. A. M. Rudd, C. A. Jones, H. M. Noble, H. G. Wildman, M. J. Dawson, C. Stylli, P. J. Sidebottom, B. Lamont, S. Lynn, and M. V. Hayes. 1998. Isolation and characterisation of an antifungal antibiotic (GR13402) with protein synthesis inhibition. J. Antibiot. 51:41-49.
14. Lortholary, O., and B. Dupont. 1997. Antifungal prophylaxis during neutropenia and immunodeficiency. Clin. Microbiol. Rev. 10:477-504.
15. Moldave, K. 1985. Eukaryotic protein synthesis. Annu. Rev. Biochem. 54: 1109-1149.
16. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution antifungal susceptibility testing of yeasts. Proposed standard M27-P. National Committee for Clinical Laboratory Standards, Wayne, Pa.
17. Oliver, S. G., and C. S. McLaughlin. 1977. The regulation of RNA synthesis in yeasts. I. Starvation experiments. Mol. Gen. Genet. 154:145-153.
18. Oliver, S. G., and J. R. Warmington. 1991. Transcription, p. 117-160. In A. H. Rose and J. S. Harrison (ed.), The yeasts, vol. 3. Metabolism and physiology of yeasts. Academic Press, Inc., San Diego, Calif.
19. Oliver, S. G., and D. H. Williamson. 1976. The conditions required for them induction of petite yeast mutants by fluorinated pyrimidines. Mol. Gen. Genet. 146:261-268.
20. Skogerson, L., and E. Wakatama. 1976. A ribosome-dependent GTPase from yeast distinct from elongation factor 2. Proc. Natl. Acad. Sci. USA 73: 73-76.
21. Triana-Alonso, F. J., K. Chakraburtty, and K. H. Nierhaus. 1995. The elongation factor 3 unique in higher fungi and essential for protein biosynthesis is an E site factor. J. Biol. Chem. 270:20473-20478.
22. Tuite, M. F. Personal communication.
23. Tuite, M. F., and J. Plesset. 1986. mRNA-dependent yeast cell-free translation systems: theory and practice. Yeast 2:35-52.
24. Walsh, T. J. 1992. Invasive fungal infections: problems and challenges for developing new antifungal compounds, p. 349-373. In J. A. Sutcliffe and N. H. Georgopapadakou (ed.), Emerging targets in antibacterial and antifungal chemotherapy. Chapman & Hall, New York, N.Y.